These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6180230)

  • 1. [Modification of the euglobulin method of determining the fibrinolytic properties of tissues].
    Golyshenkov SP; Skipetrov VP; Sokratov NV; Ruseĭkin NS
    Lab Delo; 1982; (6):31-3. PubMed ID: 6180230
    [No Abstract]   [Full Text] [Related]  

  • 2. [On activators and inhibitors of fibrinolysis in the amniotic fluid and in extracts of the placenta, decidua and myometrium of interrupted and normally terminated pregnancies].
    Slunský R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):236-43. PubMed ID: 4174664
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G
    Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426
    [No Abstract]   [Full Text] [Related]  

  • 4. [Activators and inhibitors of blood coagulation and fibrinolysis in the human placenta and myometrium].
    Uszyński M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1971; 16():159-90. PubMed ID: 5004447
    [No Abstract]   [Full Text] [Related]  

  • 5. [The coagulation and fibrinolytic properties of rabbit erythrocytes].
    Potekhin KG; Nikitin IuP; Fedenkov VI
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1972; 3(99):47-51. PubMed ID: 4265540
    [No Abstract]   [Full Text] [Related]  

  • 6. [A method of determining the fibrinolytic properties of tissues].
    Skipetrov VP
    Lab Delo; 1969; 8():482-4. PubMed ID: 4193039
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasmatic and platelet anti-plasmins and anti-activators.
    Den Ottolander GJ; Leijnse B; Cremer-Elfrink HM
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):404-15. PubMed ID: 4232162
    [No Abstract]   [Full Text] [Related]  

  • 8. [The fundamental and clinical studies on fibronlytic enzyme systems. II. On the fibrinolytic enzyme system in blood, tissue, and urine].
    Kato H
    Nihon Hinyokika Gakkai Zasshi; 1967 May; 58(5):506-15. PubMed ID: 4229201
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the development of blood coagulation disorders in pregnancy interruption. VI].
    Slunský R
    Z Geburtshilfe Gynakol; 1967 May; 167(1):42-50. PubMed ID: 5586021
    [No Abstract]   [Full Text] [Related]  

  • 10. [Investigations on the fibrinolytic activity of human urine. 3. Effect of hyperbaric oxygen on the fibrinolytic activities in blood and urine].
    Sugiura H; Suzuki S; Kato S
    Nihon Hinyokika Gakkai Zasshi; 1972 Jan; 63(1):43-56. PubMed ID: 4259205
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation of the fibrinolytic substances in euglobulin solution of man and dog plasma by gel filtration using Sephadex G-100 and 200.
    Nitta H; Sugie I; Sato S; Morimoto S; Miyachi S
    Nagoya Med J; 1967 Mar; 13(1):23-32. PubMed ID: 6075636
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative method for determination of fibrinolytic agents released from tissue cultures].
    Pandolfi M; Astedt B
    Haematologica; 1973; 58(7):481-90. PubMed ID: 4200985
    [No Abstract]   [Full Text] [Related]  

  • 13. [Estimation of the plasminogen activation inhibitor in the euglobulin test].
    Januszko T; Buluk K; Uszyńska-Folejewska R; Uszyński M
    Ginekol Pol; 1966 Feb; 37(2):137-41. PubMed ID: 5942329
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fibrinolytic properties of the wall of the aorta in man].
    Andreenko GV; Nikitin IuP; Tabarovskaia TA
    Dokl Akad Nauk SSSR; 1968 Sep; 182(2):469-70. PubMed ID: 5745527
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental studies on fibrinolytic dynamics of decubital ulcer in oral mucosa (author's transl)].
    Hamasaki E
    Igaku Kenkyu; 1981 Mar; 51(1):33-49. PubMed ID: 7324806
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of epsilon-aminocaproylaminoacids on fibrinolytic and caseinolytic activity of euglobulin fraction.
    Midura-Nowaczek K; Bruzgo I; Popławski J; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1998; 55(2):159-61. PubMed ID: 9673155
    [No Abstract]   [Full Text] [Related]  

  • 17. [New assay methods on blood clotting and fibrinolytic factors (author's transl)].
    Fujimaki M
    Rinsho Byori; 1982 Jan; 30(1):44-53. PubMed ID: 7087230
    [No Abstract]   [Full Text] [Related]  

  • 18. [A pycnometric method for determining the biological activity of a tissue emulsion].
    Konstantinov P
    Veterinariia; 1966 Aug; 43(8):78-9. PubMed ID: 5993307
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on fibrinolytic inhibitors during pregnancy.
    Hedner U; Astedt B
    Acta Obstet Gynecol Scand; 1971; 50(1):99-103. PubMed ID: 5558602
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial characterization of a fibrinolytic inhibitor produced by cultured endothelial cells derived from human umbilical vein.
    Esnard F; Dupuy E; Dosne AM; Bodevin E
    Thromb Haemost; 1982 Apr; 47(2):128-31. PubMed ID: 7101231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.